Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T73495 | ||||
Target Name | Glutamate receptor ionotropic kainate 1 (GRIK1) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | Topiramate | Drug Info | Ki = 0.87 nM | [10] | |
Drug Info | Ki = 140 nM | [9] | |||
Drug Info | Ki = 1150 nM | [7] | |||
(2S,4R)-4-(3-Methoxy-3-oxopropyl)glutamic Acid | Drug Info | Ki = 42.8 nM | [6] | ||
2-(3-(3-bromophenyl)ureido)-4-chlorobenzoic acid | Drug Info | IC50 = 4800 nM | [3] | ||
2-(3-bromobenzoylamino)-4-chlorobenzoic acid | Drug Info | IC50 = 19000 nM | [3] | ||
2-AMINO-3-(4-HYDROXY-1,2,5-OXADIAZOL-3-YL)PROPIONIC ACID (STRUCTURAL MIX) | Drug Info | Ki = 8100 nM | [9] | ||
2S,4R-4-METHYLGLUTAMATE | Drug Info | Ki = 0.663 nM | [6] | ||
DIHYDROKAINATE | Drug Info | Ki = 8180 nM | [5] | ||
Domoric acid | Drug Info | Ki = 1.11 nM | [6] | ||
LY293558 | Drug Info | IC50 = 230 nM | [1] | ||
NBQX | Drug Info | IC50 = 31 nM | [1] | ||
S-ATPO | Drug Info | Ki = 2900 nM | [8] | ||
TQX-173 | Drug Info | IC50 = 11600 nM | [2] | ||
UBP-302 | Drug Info | IC50 = 15000 nM | [4] | ||
YM-90K | Drug Info | IC50 = 260 nM | [1] | ||
[3H]kainate | Drug Info | Ki = 75.9 nM | [6] | ||
[3H]quisqualate | Drug Info | Ki = 171 nM | [6] | ||
References | |||||
REF 1 | 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with... Bioorg Med Chem Lett. 2000 May 15;10(10):1133-7. | ||||
REF 2 | Synthesis, ionotropic glutamate receptor binding affinity, and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,... J Med Chem. 2001 Sep 13;44(19):3157-65. | ||||
REF 3 | Bioisosteric modifications of 2-arylureidobenzoic acids: selective noncompetitive antagonists for the homomeric kainate receptor subtype GluR5. J Med Chem. 2004 Dec 30;47(27):6948-57. | ||||
REF 4 | Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Syn... J Med Chem. 2006 Oct 5;49(20):6015-26. | ||||
REF 5 | Chemo-enzymatic synthesis of (2S,4R)-2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid: a novel selective inhibitor of human exci... J Med Chem. 2008 Jul 24;51(14):4085-92. | ||||
REF 6 | Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotr... J Med Chem. 2008 Jul 24;51(14):4093-103. | ||||
REF 7 | 1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of pot... J Med Chem. 2008 Oct 23;51(20):6614-8. | ||||
REF 8 | 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands. Bioorg Med Chem. 2009 Sep 1;17(17):6390-401. | ||||
REF 9 | 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological charact... J Med Chem. 2010 May 27;53(10):4110-8. | ||||
REF 10 | Carbonic anhydrase inhibitors as anticonvulsant agents. Curr Top Med Chem. 2007;7(9):855-64. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.